Article
Suppression of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva Using AAV Gene Delivery
2022-06-10
Abstract excerpt
<title>Abstract</title> <p>Progressive heterotopic ossification (HO) is the most disabling and defining feature of fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. More than 95% of FOP patients harbor a heterozygous activating mutation (c.617G>A;p.R206H) in the Activin A Receptor Type 1 (ACVR1). Currently, there are no definitive preventions or treatments. Gene therapy is thus an attra...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 26d921cf-7788-5ca7-92b7-7c05273a6b6e
- DOI
- 10.21203/rs.3.rs-1646941/v1
